All the vaccine trials are following participants for over 2 years, at which point many of the 1-in-10000 effects should be known. If you look at previous problematic vaccines [2], most rare side effects (> 1-in-100000) were only seen after MILLIONS of innoculations, meaning you only see them in Phase 4 (post-approval) studies as they are extremely rare. Given the high case fatality rate of COVID-19 [3], the risk of an unseen extremely rare reaction is much lower than the risk of dying from COVID-19, so general speaking, you should get vaccinated.
[1] https://clinicaltrials.gov/ct2/show/NCT04470427#contactlocat...
[2] https://www.cdc.gov/vaccinesafety/concerns/concerns-history....
Because obviously not getting vaccinated when everybody else does is almost always the best choice game-theoretically speaking; it doesn't really say anything on the vaccine (it may say more on the civic sense of the individual).
P(death) < 0.05% for the vast majority of the population (Age < 65) vs P(unknown) long term harm in life quality, my wild estimate: P(0.1%). It's within the same order of magnitude.
I'd take the vaccine in a heartbeat, long term effects and all, if P(death) was 10% or higher.
It's an unknown vs an unknown. Novel virus, novel immunization (first mRNA or maybe first widespread modified adenovirus)
P(covid death or long term harm) < 0.05%
vs.
P(vaccine long term harm) = ?
since my estimate is they're about the same order of magnitude, I prefer to take the devil-I-know vs. the small-scale-tested vaccine.I model the potential harm based on a similarly rushed vaccine of 1976 which caused a large increase in cases of Guillain-Barré Syndrome [0]. Longer trials and phase IV monitoring was instituted in response to this rushed vaccine.
I fully admit that I am not up to speed in proven COVID-19 medium- or long-term effects beyond having seen headlines, but to essentially assume none when there have been very obvious and multi-faceted indications of them implies you must have a very good basis of research to base your estimate on. Care to share?
For example, IFR(age<65) in geneva[0] is 0.0045%. multiply by 10 to include also long term harm, you get 0.045%.
[0] https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099...
I will note that the cited 0.0045% infection fatality rate number is quite old/outdated (June 1st). It's not easy to match different areas under the age curve (which seems to be exponential) and that it can vary a lot by region, but here is a review paper which has your number for ages 0-34 (Table 3) and (substantially) higher ones for ages above that:
https://www.medrxiv.org/content/10.1101/2020.07.23.20160895v...
There is a reason vaccine trials normally take several years. I'll wait until we're a few years into phase IV trials, thankyouverymuch.